Skip to content
DefDex

Federal award

DMS PHARMACEUTICAL GROUP INC

70B06C18P00000006

Contract

Obligated and Ceiling

Obligated (net)
$49,031.40
Ceiling (potential value, not spending)
$49,031.40
Current value
$49,031.40
Gross positive obligations
$49,031.40

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
DMS PHARMACEUTICAL GROUP INC · PX72BSBQTKJ3
Owner company
DMS Pharmaceutical GroupBasis direct: the recipient is the company's own reviewed UEI.
Reported parent
DMS PHARMACEUTICAL GROUP INC · PX72BSBQTKJ3
Awarding agency
Department of Homeland Security · sub-agency 7014 · office 70B06C
Funding agency
Department of Homeland Security · sub-agency 7014
Product or service (PSC)
6505 · DRUGS AND BIOLOGICALS
Industry (NAICS)
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
PIID
70B06C18P00000006
Award type code
B
Actions
1 · Nov 1, 2017 to Nov 1, 2017
Why it is listed
reviewed company, $10k or more

Open this award on USAspending →

Action History1

Award actions
DateFYModAction typeObligationCompany in company totals
Nov 1, 2017FY20180—$49,031.40

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.